KLK3 and cancer: While PSA is overexpressed in prostate cancer, its utility is limited given that (i) it cannot discriminate between indolent and aggressive disease (ii) specificity decreases with age, and (iii) overexpression is not restricted to malignant tumours giving rise to false positives.